Mycoplasmas are common and hard-to-spot contaminants in biomanufacturing. These ultra-small bacteria can creep into cell culture and proliferate without visible signs, eventually disrupting cell health and jeopardizing the quality and safety of biopharmaceuticals. In this webinar, Sharon Rouw will discuss how DNA-based testing improves mycoplasma detection sensitivity and accuracy, enabling researchers to catch contaminants early and ensure safe biotherapeutic production.
Topics to be covered:
- DNA-based approaches for mycoplasma testing
- The advantages of using genomic DNA over traditional methods
- Key considerations for adopting DNA-based testing in biotherapeutic development
Wednesday, July 16th, 2025 | 11:00 AM - 12:00 PM Eastern Time
This webinar will be available to view live and on demand.
Speaker
Sharon Rouw
Product Manager
Thermo Fisher Scientific
